In a filing, Relay Therapeutics Inc revealed its insider Rahmer Peter unloaded Company’s shares for reported $0.14 million on Jan 03 ’25. In the deal valued at $4.30 per share,32,177 shares were sold. As a result of this transaction, Rahmer Peter now holds 325,330 shares worth roughly $1.49 million.
Then, Rahmer Peter sold 32,156 shares, generating $133,447 in total proceeds. Upon selling the shares at $4.15, the insider now owns 357,507 shares.
Before that, Rahmer Peter sold 16,576 shares. Relay Therapeutics Inc shares valued at $73,763 were divested by the insider at a price of $4.45 per share. As a result of the transaction, Rahmer Peter now holds 308,754 shares, worth roughly $1.41 million.
Jefferies upgraded its Relay Therapeutics Inc [RLAY] rating to a Buy from a a Hold in a research note published on September 10, 2024; the price target was increased to $16 from $10.60. Oppenheimer also remained covering RLAY and has decreased its forecast on September 10, 2024 with a “Perform” recommendation from previously “an Outperform” rating. Barclays revised its rating on May 10, 2024. It rated RLAY as “an Overweight” which previously was an “an Equal weight”.
Price Performance Review of RLAY
On Monday, Relay Therapeutics Inc [NASDAQ:RLAY] saw its stock jump 3.39% to $4.57. Over the last five days, the stock has gained 4.82%. Relay Therapeutics Inc shares have risen nearly 10.92% since the year began. Nevertheless, the stocks have fallen -60.71% over the past one year. While a 52-week high of $12.14 was reached on 01/06/25, a 52-week low of $4.01 was recorded on 01/02/25. SMA at 50 days reached $5.00, while 200 days put it at $6.59.
Levels Of Support And Resistance For RLAY Stock
The 24-hour chart illustrates a support level at 4.43, which if violated will result in even more drops to 4.28. On the upside, there is a resistance level at 4.69. A further resistance level may holdings at 4.80. The Relative Strength Index (RSI) on the 14-day chart is 49.63, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.08, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 44.83%. Stochastics %K at 40.19% indicates the stock is a holding.
How much short interest is there in Relay Therapeutics Inc?
A steep rise in short interest was recorded in Relay Therapeutics Inc stocks on 2024-12-13, growing by 0.47 million shares to a total of 12.08 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 11.61 million shares. There was a rise of 3.89%, which implies that there is a positive sentiment for the stock.
